drugset / Trial / NCT05969041
Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
NaSingle-groupOpen-labelTreatment
Summary
MYE Symphony is a multicenter, open-label, Phase 1 first-in-human study to assess the safety, tolerability, and define the RP2D of MT-302 in participants with advanced epithelial cancer.
Timeline
- Start
- 2023-08-02
- Primary completion
- 2027-08-31
- Completion
- 2028-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MT-302 | Unknown | — | Intravenous |